Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption.
Dermatol Ther
; 23(5): 553-5, 2010.
Article
em En
| MEDLINE
| ID: mdl-20868411
ABSTRACT
Vandetanib is an inhibitor of the vascular endothelial growth factor receptor 2 tyrosine kinase and the epidermal growth factor receptor tyrosine kinase, recently used in the treatment of different tumors. We describe a case of a photo-allergic reaction to vandetanib in an 80-year-old Caucasian woman affected by metastatic non-small cell lung cancer. Phototoxic reactions to vandetanib have been rarely reported in the literature. Dermatologists should be aware of this cutaneous side effect of vandetanib treatment and affected patients should be counseled to use adequate sun protection.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piperidinas
/
Quinazolinas
/
Dermatite Fotoalérgica
/
Toxidermias
/
Receptor 2 de Fatores de Crescimento do Endotélio Vascular
/
Inibidores Enzimáticos
/
Antineoplásicos
Limite:
Aged80
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article